Table of Contents

Trans-dimerization of Amyloid Precursor Protein Family Members Induces Pre- and Postsynaptic Differentiation through Distinct Signaling Pathways

  1. Stefan Kins1
  1. 1Department of Human Biology and Human Genetics, RPTU University Kaiserslautern-Landau, Kaiserslautern 67663, Germany
  2. 2Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen 37075, Germany
  3. 3Departments of Computational Biology, RPTU University Kaiserslautern-Landau, Kaiserslautern 67663, Germany
  4. 4Molecular Biotechnology and Systems Biology, RPTU University Kaiserslautern-Landau, Kaiserslautern 67663, Germany
  5. 5Nanophysiology, RPTU University Kaiserslautern-Landau, Kaiserslautern 67663, Germany
  6. 6Department of Functional Genomics, Institute for Pharmacy and Molecular Biotechnology, University of Heidelberg, Heidelberg 69120, Germany
  7. 7Institute of Anatomy and Cell Biology, University of Heidelberg, Heidelberg 69120, Germany
  8. 8Department of Cellular and Molecular Biology, University of Medicine, Pharmacy, Science and Technology “G.E. Palade” of Târgu Mures, Târgu Mureș 540 139, Romania
  9. 9Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut (PEI), Langen 63225, Germany
  1. Correspondence should be addressed to Stefan Kins at kins{at}rptu.de.
  1. Author contributions: S.E., S.S., T.Ma., E.K., U.C.M., and S.K. designed research; R.R., N.F., M.F., F.S., M.B., and V.B. performed research; C.J.B. contributed unpublished reagents/analytic tools; R.R., N.F., C.O., T.Mü., and F.S. analyzed data; S.S., M.F., C.O., F.S., M.S., and S.K. wrote the paper.

Abstract

The amyloid precursor protein (APP), a key factor in Alzheimer's disease (AD) pathology, and its two mammalian homologs, amyloid precursor-like proteins 1 and 2 (APLP1 and APLP2), are considered as members of the synaptic adhesion molecule (SAM) family. They are localized to the pre- and postsynapse, form trans-cellular dimers, and have been shown to induce presynaptic differentiation in a heterologous synapse formation assay. We demonstrate that expression of all APP family members in non-neuronal cells also promotes dendritic excitatory postsynaptic differentiation in primary mouse neurons of either sex, similar to Neurexin1β and other SAMs. Synaptogenic activity was decreased by deletion of the E1 domain and increased upon inhibition of soluble APP (sAPP) generation, reinforcing that trans-cellular interaction of APP/APLPs can induce synaptogenesis. Consistent with this, the capacity of heterologously expressed APP to induce postsynaptic specializations in contacting dendrites was reduced by the absence of APP family members at the postsynaptic site and was lost in conditional triple knock-out (cTKO) neurons. Pharmacological analyses revealed that heterologous formation of pre- and postsynapses relies on proper microtubule and actin cytoskeleton dynamics, as well as the MAP kinase pathway, similar to what has been shown for Neurexin1β and Neuroligin1. However, inhibition of the PI3K/Akt pathway selectively impaired APP-induced postsynaptic differentiation, suggesting that distinct APP signaling pathways are required for pre- and postsynaptic differentiation. Collectively, our data highlight the role of all APP family members as SAMs in trans-synaptic signaling, providing key insights into their physiological function and advancing our understanding of AD-related synaptopathies.

Footnotes

  • We thank Dagmar Groß, Katrin Lesoine, and Julia Gobbert for excellent technical assistance. Furthermore, we thank Dr. Harald Witte and Prof. Peter Scheiffele for kindly providing the Neurexin1β and Neuroligin1 plasmids. We thank Gundula Braun and Manuela Gallet (Paul-Ehrlich-Institut, Germany) for excellent technical support regarding AAV Vector production. We thank the DFG for the funding to S.K. (Kl 819/9-1; INST 248/396-1 FUGG) and U.C.M. (MU1457/15-1 and MU1457/17-1) and the Romanian Ministry of Research and Innovation for the grant CNCS-UEFIS-CDI:PN-III-P4-ID-PCE-2021-1089 to E.K. Figures 1A, 2F, 4K, and 5E were created using BioRender (BioRender.com/cmsw4ox).

  • ↵*R.R. and N.F. contributed equally to this work.

  • The authors declare no competing financial interests.

  • This paper contains supplemental material available at: https://doi.org/10.1523/JNEUROSCI.0701-25.2026

  • Received April 8, 2025.
  • Revision received May 5, 2026.
  • Accepted June 12, 2026.
Responses to This Article
Be the first to respond to this article
Advertisement